Presentation will include an update on the development and launch preparations of Cylembio™ (imsapepimut and etimupepimut, adjuvanted)NEW YORK, ...

Investors have taken to punishing pharma companies that appear unable to gauge demand for their top products.

Merck & Co.'s heavy reliance on its cancer drug Keytruda, which accounts for nearly half of the company's revenue, is raising investor concerns as the drug's patent expiration approaches in 2028 ...

Merck stock fell in premarket trading Tuesday after the company said sales of its blockbuster HPV vaccine, Gardasil, declined 17% in the fourth quarter of 2024. Shares of the pharmaceutical company ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded. [Operator instructions] I would now like to turn the call over to Mr. Peter ...

and the commercial opportunity they represent." He pointed to the company's efforts to diversify its pipeline and highlighted recent findings from a study evaluating a subcutaneous formulation of ...

Steinfeld is teaming up with pharmaceutical company Novartis to raise awareness about breast cancer with a bold and empowering commercial that will air on one of the biggest platforms in the world ...

After more than a decade-long absence, a Clydesdale foal has returned to the beer brand's Super Bowl commercial. Budweiser's 2025 Super Bowl ad, titled "First Delivery," features a young ...

WASHINGTON — Budweiser is returning to the Super Bowl advertising space with a heartwarming commercial featuring its signature Clydesdale horses. The commercial, which was unveiled just two ...

The commercial ends with the foal triumphantly rolling the keg through the doors of a bar, followed by the brand's message, "Delivering since 1876." In the final shot, the foal gazes into the bar ...

Results have been announced from a Phase III trial of Merck & Co’s (NYSE: MRK) anti-PD-1 therapy Keytruda (pembrolizumab ... executive appointments, commercial strategy and financial results. Daily ...